AavantiBio
About:
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Website: https://www.aavantibio.com/
Top Investors: RA Capital Management, Perceptive Advisors, Bain Capital Life Sciences, SV Health Investors, Sarepta Therapeutics
Description:
Total Funding Amount:
$107M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2020-01-01
Founders:
Barry Byrne, Manuela Corti
Number of Employees:
11-50
Last Funding Date:
2020-10-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai